Objective
Muscle weakness and loss of muscle cytoarchitecture are associated with several myopathies, many of which still of unknown genetic cause, and with other pathologic states, such as the muscle atrophy that results from aging, cancer or cardiac infarction (cardiac cachexia). Because of the changes in our life habits and in the average life expectancy of our societies, treating muscle weakness by increasing muscle mass or by boosting the regenerative potential of muscle tissue is becoming a major goal for the clinical industry as well as for healthcare agencies. Insulin Growth Factor 1 (IGF1) can play an important role in improving muscle function during diseased states or along the aging process. In fact, it can increase the regenerative potential of muscle tissue and/or stimulate local hypertrophy, an event that ultimately requires for active remodelling of the contractile apparatus.
However, IGF1 regulation is particularly complex, since different isoforms of the pro-hormone have been described, differing in their C-terminal E-peptides. Overall, little is known about the events controlled by alternative IGF1 isoforms specifically in muscle cells, or their importance for remodelling/stability of myofibrillar apparatus. Elucidating any direct effect exerted by IGF1 E-peptides on muscle differentiation and myofibrillogenesis, or how they influence the modes of function of IGF1, is crucial for our understanding of this system and for our capacity to modulate it to attenuate age- or disease-associated muscle weakness.
We propose the following aims:
1. To characterise the events under the control of IGF1 specifically in muscle cells;
2. To assess the role of IGF1 E-peptides on muscle cells, either as direct effectors or as modulators of IGF1 function;
3. To define the contribution of IGF1 signalling to the stability and remodelling of the myofibrillar apparatus in skeletal muscle fibres.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
- natural sciences biological sciences biochemistry biomolecules
- medical and health sciences clinical medicine oncology
- medical and health sciences basic medicine physiology homeostasis
You need to log in or register to use this function
Keywords
Project’s keywords as indicated by the project coordinator. Not to be confused with the EuroSciVoc taxonomy (Fields of science)
Project’s keywords as indicated by the project coordinator. Not to be confused with the EuroSciVoc taxonomy (Fields of science)
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
FP6-2004-MOBILITY-12
See other projects for this call
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
IRG - Marie Curie actions-International re-integration grants
Coordinator
HEILDEBERG
Germany
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.